Recent Patents on Endocrine, Metabolic & Immune Drug Discovery

ISSN (Print): 1872-2148
ISSN (Online): 2212-3334

Volume 11 , Issue 0 , 2017

Back Journal Home
Topic(s) Covered

1 Topic(s)

Covered Disease(s)

1 Disease(s)


Aims & Scope

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery publishes review and research articles, and guest edited thematic issues on recent patents in the field of endocrine, metabolic and immune drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in endocrine, metabolic and immune drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to endocrine, metabolic and immune drug discovery.

Abstracted/Indexed in

Cambridge Scientific Abstracts (CSA)/ProQuest,Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, EMBASE, Emerging Sources Citation Index (ESCI) by Clarivate Analytics, Genamics JournalSeek, Google Scholar, J-Gate, JournalTOCs,MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed, METADEX, PubsHub, QOAM, Scopus, Suweco CZ, TOC Premier and Ulrich's Periodicals Directory

Authors' Comments

As being a Diabetes research scientist and researcher, it was a great pleasure working with one of the Bentham Science Publications, “Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2013.

The “quick” response from the journal publication team at every step was one of the unique characteristics as compared to other international journals.

Right from the submission till the actual publication of my manuscript, I felt that the journal’s staff is very responsible and serious towards the researchers and their work, keeping me informed and involved at every step. Apart from the quick response, the overall guidance provided by the journal’s publication team was commendable. There were no unnecessary details, and the cordial environment makes the researchers more comfortable throughout the process of publication.

After the publication, offers/trial send by the staff to the authors encourage them towards further research and publication submissions. I had never been offered these unique post-publication services by any other publishers before. This ensures that the Bentham Science team will remain in contact with the authors and researches even after the publication process is over.

I will recommend the journals to my colleagues to consider for publishing their own work. In future as well, I will consider the journal “Recent Patents on Endocrine, Metabolic & Immune Drug Discovery” for submitting my original research.

Dr. Kamran Mahmood Ahmed A. Aziz
(Diabetology Clinic, Aseer Diabetes Center of Aseer Central Hospital, Abha, Saudi Arabia)

Has contributed: Effect of Fasting Ramadan in Diabetes Control Status - Application of Extensive Diabetes Education, Serum Creatinine with HbA1c Statistical ANOVA and Regression Models to Prevent Hypoglycemia

© 2022 Bentham Science Publishers | Privacy Policy